Investigation into conolidine has brought about discovery of the opioid receptor in the human body referred to as ACKR3/CXCR7. ACKR3 seems to be the most desired target for conolidine, which also disregards the other four classical opioid receptors(3). There is certainly interest in working with conolidine as a pain-reliever https://charlest086suv7.onzeblog.com/profile